Navigation Links
Ipsogen Launches MapQuant Dx(TM) Genomic Grade Test to Identify Breast Cancer Patients who Benefit From Chemotherapy
Date:5/30/2008

By Improving the Accuracy of Tumor Grading, MapQuant Dx(TM) Genomic Grade

Could Spare Tens of Thousands Chemotherapy Treatments per Year

ASCO Annual Meeting, May 30, 2008 - booth 23128

CHICAGO, May 30 /PRNewswire/ -- Ipsogen SA (Marseilles, France and New Haven, CT, USA), a cancer profiler that markets molecular diagnostic assays for leukaemia announced today that it is entering the breast cancer diagnostic market with the European launch of MapQuant Dx(TM) Genomic Grade. MapQuant Dx(TM) Genomic Grade is the very first molecular diagnostic test to accurately measure tumor grade, a consensus indicator of tumor proliferation, risk of metastasis and response to chemotherapy.

Histological tumor grading is considered a decision factor in most national and international guidelines to breast cancer treatment. While it is generally recommended to treat high-grade "grade 3" breast carcinoma with chemotherapy because they are chemosensitive and will often recur otherwise. By contrast, most low-grade "grade 1" tumors should not be treated with chemotherapy because they have a good prognosis and are often chemo-insensitive.

A key clinical issue is how to treat the 50% of breast cancers tested today as uncertain/intermediate "grade 2" by current methods - based on the visual examination of tumor sections under the microscope.

MapQuant Dx(TM) Genomic Grade test directly measures the expression of the 97 genes that best characterize high-grade vs. low-grade tumors. It can resolve these "grade 2" tumors into either "grade 1" or "grade 3" tumors in 80 % of cases.

MapQuant Dx(TM) Genomic Grade test is especially useful when tumor grade information can be decisive for prescribing a chemotherapy. According to most guidelines, this is the case for hormone-sensitive (ER+) node-negative (N-) invasive breast carcinoma.

"In these patients, most grade 2 tumors are treated by chemotherapy and hormonotherapy. It is expected
'/>"/>

SOURCE Ipsogen SA
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Gen-Probe Launches in Europe CE-Marked APTIMA(R) HPV Assay for Detection of Human Papillomavirus
2. Smith & Nephew Endoscopy Launches New, Reusable Cannula Line for Hip Arthroscopy
3. Abbott Launches Next-Generation StarClose(R) SE Vascular Closure System
4. Shire Launches Nationwide Adult ADHD Mobile Awareness Tour
5. BioSpace Launches 6th Edition of Bio NC(TM) Hotbed Campaign
6. Enterix Inc. Launches Its Point-of-Care Test for Colorectal Cancer Screening
7. LifeQuest World Launches Immune System Boosting Supplement to the North American Market
8. ExonHit Launches Rat Genome SpliceArray(TM) Products to Expand High Resolution Gene Expression Profiling for use in Disease Modeling and Toxicogenomics
9. Biocept Launches Noninvasive Prenatal Rh(D) Diagnostic at Annual ACOG Scientific Meeting
10. Better Nutrition Launches 2008 Summer Nutrition Tour
11. HC&B Healthcare Launches HC&B Digital
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... PALM BEACH, Fla. , July 11, 2014 /PRNewswire-iReach/ ... variety of high-quality peptides that are used solely in ... To honor two successful years in business, Maxim Peptide, ... LLC, has just launched a new and updated website ... the research blog section has been updated with fascinating ...
(Date:7/11/2014)... July 11, 2014 , Not for ... into or from any jurisdiction where to do so would ... Shire plc ("Shire" or the "Company") (LSE: SHP, ... afternoon.  Shire confirms it has held a meeting with representatives ... Shire without the prior agreement or approval of AbbVie. ...
(Date:7/11/2014)... July 11, 2014 Research and Markets ... Technology Market - Global Industry Analysis, Size, Share, Growth, ... offering. http://photos.prnewswire.com/prnh/20130307/600769 ... acids (either DNA or RNA) into cells. This technology ... cancer cells and protein metabolism by affecting the nuclear ...
(Date:7/11/2014)... July 11, 2014 BCC Research ( ... DIGITAL POLYMERASE CHAIN REACTION (PCR) TECHNOLOGY: GLOBAL MARKETS , ... technology reached nearly $140 billion in 2013. This is ... a five-year compound annual growth rate (CAGR) of 28.6%. ... of interesting and exciting possibilities within the broader PCR ...
Breaking Biology Technology:Maxim Peptide Celebrates Second Anniversary Online with an Updated Website and Special Deals Section 2Shire plc - Statement re: Media Speculation 2International Transfection Technology Market - Industry Analysis, Size, Share, Growth, Trends and Forecast to 2019 2Global Market for Digital Polymerase Chain Reaction Technology to Reach $490 Billion by 2018; Equipment Sector Accounts for the Fastest Growing Segment With 33% CAGR 2Global Market for Digital Polymerase Chain Reaction Technology to Reach $490 Billion by 2018; Equipment Sector Accounts for the Fastest Growing Segment With 33% CAGR 3
... 11 Amicus Therapeutics,(Nasdaq: FOLD ), today announced ... at the 5th Annual Lazard Capital Markets Healthcare,Conference in ... p.m. EST., A webcast and audio archive of ... at http://www.amicustherapeutics.com . Participants,should allow approximately five to ...
... a privately-held,biopharmaceutical company focused on developing novel cancer ... viral vector, today announced,that executive management will participate ... to be held November 10 through November 12,2008 ... York City. Frank D. Stonebanks,President and Chief Executive ...
... Calif., Nov. 11 Cord Blood,America, Inc. (OTC ... preservation company ( http://www.cordblood-america.com ) focused on,bringing the ... nationwide and,internationally, said today that the stem cell ... Obama intends to use his executive,authority to reverse ...
Cached Biology Technology:Cord Blood America Salutes President-Elect Obama's Promise to Lift Restrictions on Stem Cell Research 2
(Date:7/11/2014)... Wildlife Conservation Society shows that no-take zones in ... such as lobster, conch, and fish recover from ... areas. , The reporttitled "Review of the Benefits ... literature from no-take areas around the world. The ... recognized expert in marine protected areas and fisheries ...
(Date:7/11/2014)... 11, 2014--Researchers at the Department of Energy,s Oak ... awards, presented by R&D Magazine in recognition of ... awards recognize the tremendous value of our National ... and development at the National Labs continues to ... pursue the scientific and technological innovations necessary to ...
(Date:7/11/2014)... were many fires burning in eastern New South Wales, ... 11. , At 03:35 UTC on July 11 (12:35 ... Aqua passed over eastern New South Wales (NSW), the ... visible image of the region and spotted smoke (light ... MODIS,s thermal bands, are outlined in red. , The ...
Breaking Biology News(10 mins):Belize's lobster, conch, and fish populations rebuild in no-take zones 2ORNL wins eight R&D 100s 2ORNL wins eight R&D 100s 3ORNL wins eight R&D 100s 4
... OTO EXPO of the American Academy of Otolaryngology Head ... nose, and throat doctors in the world, will convene September ... 305 scientific research sessions, 594 posters, and several hundred instruction ... opportunity for journalists from around the world to cover breaking ...
... Carolina State University researcher has shown that water-gel-based solar ... cells to produce electricity. The findings prove the concept ... They also have the potential to be less expensive ... solar cells. The bendable devices are composed of ...
... determined that teenagers who have abortions are no more likely ... whose pregnancies do not end in abortion. The study ... California, San Francisco, is the first to use both depression ... of adolescents. The researchers found that young women in ...
Cached Biology News:2010 AAO-HNSF miniseminars: Sunday, Sept. 26, 2010 22010 AAO-HNSF miniseminars: Sunday, Sept. 26, 2010 3Mimicking nature, water-based 'artificial leaf' produces electricity 2National study: Abortion does not cause depression or low self-esteem in adolescents 2National study: Abortion does not cause depression or low self-esteem in adolescents 3
Mouse Anti-Amyloid beta [1-16], clone 6E10, Monoclonal Antibody...
The pCDF Expression System 1 plus Competent Cells contains 10 µg of pET-45b(+) DNA. pET-45b carries an N-terminal His•Tag ® coding sequence that is cleavable with enterokinase as well...
Nucleobindin 1 [NUCB1]...
Request Info...
Biology Products: